IMARC Group’s report “PET-CT Scanner Devices Market Report: By Type (Stationary Scanners, Portable/Mobile Scanners), By Number of Slices (Low-Slice Scanners (< 64 Slices), Medium Slice Scanners (64 Slices), High-Slice Scanners (> 64 Slices)), by Isotope and Detector Type (Fluorodeoxyglucose (FDG), 62Cu ATSM, 18F Sodium Fluoride, FMISO, Gallium, Thallium, and Others), by Service Provider (Hospitals, Diagnostic Centers, Research Institutes), Application (Oncology, Neurology, Cardiology, and Others), and by Region 2025-2033.The global PET-CT scanner device market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.2 Billion by 2033, exhibiting a growth rate (CAGR) of 3.44% during 2025-2033.
Get a Mr./Ms. pull PDF of this report:Â https://www.imarcgroup.com/pet-ct-scanner-device-market/requestsample
Global PET-CT Scanner Equipment Market Trends
The move towards personalized medicine drives the market for PET-CT scanners. Personalized treatment means that every patient gets a treatment plan based on his or her own genetic makeup and the characteristics of the disease. PET-CT scans become very important in this paradigm because these techniques offer images that also provide a way of understanding diseases at the molecular and functional levels, which in turn makes more precise imaging possible for better diagnosis, treatment planning, and monitoring, particularly in oncology, where understanding tumor biology at a molecular level is critical. The personal viewpoint of medicine has been noting a transformation, and this trend will also encourage the health industry to procure PET-CTs. The future expansion of personalized uses inevitably comes with increased demand for such advanced imaging technologies as PET-CT.
Factors influencing the growth of the PET-CT scanner devices industry:
- Advancements in Medical Imaging Technology:
The continuous development of medical imaging technology is propelling market growth. The combination of positron emission tomography (PET) and computed tomography (CT) into one device enhances both diagnostic accuracy and patient care. Innovations such as higher resolution, faster scan times, and better image-reconstruction algorithms have further enhanced the capabilities of PET-CT scanners, rendering them indispensable for the detection and tracking of many diseases, especially cancer. The new hybrid imaging systems able to fuse PET-CT with other modalities such as MRI simply add to their diagnostic potential, commanding huge investments and adoption in healthcare facilities worldwide. This advancement in technology not only enhances patient outcomes but also improves clinical work efficiency, rendering the acceptance of PET-CT scanners increasingly attractive to healthcare providers.
- Rising Prevalence of Chronic Diseases:
Another one of the major factors that would likely increase the usage of PET-CT scanners is the prevailing chronic diseases today, particularly cancer and vascular disorders. There is an urgent need for accurate and timely diagnosis which will be helped by these scanners in such cases. The worldwide population is aging substantially, which would also mean a larger number of people who could develop chronic ailments due to old age. Scanning images made by PET-CT scanners help stage, evaluate treatment response, and find metastatic sites, where they become immediate considerations under chronic disease management. The further increase in awareness about the importance of early diagnosis and the subsequent increase in screening programs is also driving the uptake of these PET-CT scanners.
- Government Initiatives and Healthcare Expenditure:
Government backing and rising expenditure in health care enhance market growth. Many governments across the globe are providing money for building health care infrastructure to give better diagnostic tools and improve public health outcomes. This includes funding R&D, along with the provision of subsidies and incentives for health care providers toward their uptake of current technology, thereby driving the uptake of PET-CT scanners. Second, good reimbursement schemes for diagnostic imaging procedures make such advanced technologies readily available to patients, thereby encouraging health care providers to adopt PET-CT scanners. This support from governmental bodies not only speeds up the adoption of technology, but also facilitates more health care facilities for offering advanced imaging services.
Leading companies operating in the global PET-CT Scanner Equipment industry:
- Bruker Corporation
- Canon Medical Systems USA, Inc.
- General Electric Company
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Mediso Inc.
- New Soft Inc.
- Positron Corporation
- Shimadzu Corporation
- Siemens Healthcare GmbH (Siemens AG)
- Sophie Biosciences K.K.
- United Imaging Healthcare, Inc.
- Yangzhou Kindsway Biotechnology Co., Ltd.
PET-CT Scanner Devices Market Report Segmentation:
By Type:
- Stationary scanner
- Portable Scanners/Mobile Scanners
Stationary scanners account for the largest segment due to their high image quality, reliability, and suitability for a wide range of clinical applications.
By number of slices:
- Low-slice scanner (<64-slice)
- Medium Slice Scanner (64 Slices)
- High-Slice Scanner (> 64-slice)
Medium-slice scanners (64 slices) account for the majority of the market share due to their balance between image resolution and cost-effectiveness, making them a popular choice among healthcare professionals.
By Isotope and Detector Type:
- Flurodeoxyglucose (FDG)
- 62Cu ATSM
- 18 F Sodium Fluoride
- FMISO
- gallium
- thallium
- others
Flurodeoxyglucose (FDG) shows a distinct advantage in the market due to its widespread availability, well-established efficacy in cancer imaging, and reimbursement support.
By Service Provider:
- hospital
- Diagnostic Centers
- Research Institutes
Hospitals account for the largest market share by driving comprehensive diagnostic and treatment services, including PET-CT imaging, to a wide patient population.
By Application:
- oncology
- neurology
- cardiology
- others
Oncology dominates the market, which can be attributed to the utilization of PET-CT images in cancer diagnosis, staging, treatment planning, and response assessment.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others)
- Latin America (Brazil, Mexico, and others)
- Middle East & Africa
Asia-Pacific enjoys a leading position in the PET-CT scanner devices market owing to the increasing investments in healthcare infrastructure, rising prevalence of cancer, and increasing adoption of advanced medical imaging technologies.
Note: If you need specific information that is not currently included in the scope of the report, it will be provided as part of the customization.
About us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact
IMARC Group
134 N 4th St. Brooklyn, NY 11249 United States
E-mail sales@imarcgroup.com
Phone: (D) +91 120 433 0800
USA: +1-631-791-1145
